Skip to content
CLADsolve

Paper

Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study

Evidence level: retrospective human biomarker study; abstract-only

A small retrospective study finding higher bronchoalveolar lavage M65 (a marker of epithelial cell death) in RAS than in BOS or CLAD-free controls.

As of . Primary source: Publisher record via DOI.

Summary

The study measured M30 and M65, cytokeratin-18 fragments released during epithelial cell apoptosis and total cell death, in bronchoalveolar lavage (BAL) fluid. Samples came from 26 patients with established CLAD (10 with RAS and 16 with BOS) and 19 long-term CLAD-free controls, with infection and acute rejection excluded. The abstract reports that M65 was significantly higher in RAS than in BOS and controls and correlated with worse survival after CLAD onset. The authors conclude that lung epithelial cell death is enhanced in RAS and that BAL M65 may help differentiate CLAD subtypes and serve as a prognostic marker. The cohort is small and single-centre, and the centre is not named in the abstract.

Details

doi
10.1111/tri.13444
pmid
31002407
authors
Levy L, Tigert A, Huszti E, Saito T, Mitsakakis N, Moshkelgosha S, Joe B, Boonstra KM, Tikkanen JM, Keshavjee S, Juvet SC, Martinu T
journal
Transplant International
year
2019
volume
32
issue
9
pages
965-973

Sources and links

Related

Links from this record

Linked from (derived)

Known gaps in this record

  • full text not read (abstract only)
  • funding statement and grant numbers
  • author affiliations
  • centre or centres not stated in the abstract

Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.